Wells Fargo’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $166M | Buy |
|
|||||
|
2021
Q1 | $86.6M | Sell |
|
|||||
|
2020
Q4 | $136M | Sell |
|
|||||
|
2020
Q3 | $106M | Sell |
|
|||||
|
2020
Q2 | $112M | Sell |
|
|||||
|
2020
Q1 | $120M | Sell |
|
|||||
|
2019
Q4 | $179M | Sell |
|
|||||
|
2019
Q3 | $189M | Sell |
|
|||||
|
2019
Q2 | $322M | Buy |
|
|||||
|
2019
Q1 | $282M | Buy |
|
|||||
|
2018
Q4 | $172M | Sell |
|
|||||
|
2018
Q3 | $249M | Buy |
|
|||||
|
2018
Q2 | $184M | Buy |
|
|||||
|
2018
Q1 | $146M | Buy |
|
|||||
|
2017
Q4 | $148M | Sell |
|
|||||
|
2017
Q3 | $219M | Buy |
|
|||||
|
2017
Q2 | $143M | Sell |
|
|||||
|
2017
Q1 | $145M | Sell |
|
|||||
|
2016
Q4 | $230M | Sell |
|
|||||
|
2016
Q3 | $420M | Sell |
|
|||||
|
2016
Q2 | $426M | Sell |
|
|||||
|
2016
Q1 | $644M | Sell |
|
|||||
|
2015
Q4 | $1.14B | Sell |
|
|||||
|
2015
Q3 | $975M | Buy |
|
|||||
|
2015
Q2 | $976M | Buy |
|
|||||
|
2015
Q1 | $742M | Sell |
|
|||||
|
2014
Q4 | $813M | Sell |
|
|||||
|
2014
Q3 | $747M | Sell |
|
|||||
|
2014
Q2 | $818M | Sell |
|
|||||
|
2014
Q1 | $917M | Sell |
|
|||||
|
2013
Q4 | $1.02B | Buy |
|
|||||
|
2013
Q3 | $692M | Buy |
|
|||||
|
2013
Q2 | $548M | Buy |
|